Tolterodine: Superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: A randomized controlled trial

Journal of Urology

Volumn 165, Issue 5 I, 2001, Pages 1452-1456

  Malone Lee, James ^b   Shaffu, Badi ^b   Anand, Chaman ^b   Powell, Christopher ^b  

^a ST PANCRAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Bladder; Drug tolerance; Muscarinic antagonists; Treatment outcome; Urinary incontinence

Indexed keywords

OXYBUTYNIN; TOLTERODINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; DYSURIA; FEMALE; HEADACHE; HUMAN; IRELAND; MALE; NAUSEA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE INCONTINENCE; VERTIGO; VISUAL DISORDER; XEROSTOMIA;

EID: 0035047008     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)66326-4     Document Type: Article

References (18)

1. A review of the quality of life aspects of urinary urge incontinence
2. Urinary incontinence: Prevalence and needs
3. Genuine stress incontinence and detrusor instability: A review of 200 patients
4. The overactive bladder: Pharmacologic basis of drug treatment
5. Oxybutynin: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability
6. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: Oxybutynin versus propantheline versus placebo
7. A new questionnaire to assess the quality of life of urinary incontinent women
8. Tolterodine: A new bladder selective muscarinic receptor antagonist - Preclinical pharmacological and clinical data
9. Tolterodine: A new bladder-selective antimuscarinic agent
10. Efficacy and safety of tolterodine in patients with detrusor instability: A dose- ranging study
11. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia
12. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity
13. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
14. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder
15. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis
16. Oxybutynin chloride (3 mg) in the treatment of women with idiopathic detrusor instability
17. Low dose oxybutynin for the unstable bladder
18. Oxybutynin with bladder retraining for detrusor instability in elderly people: A randomized controlled trial